Industry
Medical - Devices
iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.
Loading...
Open
76.09
Mkt cap
2.4B
Volume
246K
High
76.96
P/E Ratio
-15.65
52-wk high
124.11
Low
75.02
Div yield
N/A
52-wk low
55.92
Portfolio Pulse from
November 18, 2024 | 1:30 pm
Portfolio Pulse from
November 05, 2024 | 9:45 pm
Portfolio Pulse from Benzinga Newsdesk
November 01, 2024 | 7:40 pm
Portfolio Pulse from Benzinga Newsdesk
November 01, 2024 | 11:28 am
Portfolio Pulse from Benzinga Insights
October 31, 2024 | 5:04 pm
Portfolio Pulse from Benzinga Newsdesk
October 31, 2024 | 1:44 pm
Portfolio Pulse from Benzinga Newsdesk
October 31, 2024 | 12:48 pm
Portfolio Pulse from Benzinga Newsdesk
October 30, 2024 | 9:16 pm
Portfolio Pulse from Benzinga Newsdesk
October 30, 2024 | 8:20 pm
Portfolio Pulse from Benzinga Newsdesk
October 30, 2024 | 8:19 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.